Enasidenib

An orally available, selective, potent inhibitor of mutant IDH2 with IC50s of 100-400 nM for IDH2R140Q homodimer.

1446502-11-9

≥ 2 years

>98% (HPLC)

473.375

C19H17F6N7O

Research use only, not for human use.

IDH2

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

70R-34293 100 ug

Ask

PAab00816 100 µg

Ask

MBS3906166-01 0.5 mg

Ask

MBS3906166-02 5x 0.5 mg

Ask

MBS9523658-01 0.04 mL

Ask

MBS9523658-02 0.1 mL

Ask